<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig2" orientation="portrait" position="float">
 <label>FIG 2</label>
 <caption>
  <p>SIV coinfection reduces immune responses to ZIKV. (A to D) Percentages of Ki67
   <sup>+</sup> NK cells (A), memory CD4
   <sup>+</sup> T cells (B), memory CD8
   <sup>+</sup> T cells (C), and memory (mem) B cells (D) longitudinally pre- and post-ZIKV infection. ZIKV cohort mean percentages are illustrated by blue squares (
   <italic>n</italic> = 6), while SIV/ZIKV cohort mean percentages are illustrated by red circles (
   <italic>n</italic> = 7). 
   <italic>P</italic> values represent repeated-measures one-way ANOVA. AUCs were calculated from day 2 to day 21 post-ZIKV infection, followed by a Mann-Whitney 
   <italic>U</italic> test comparison between groups. Error bars represent standard deviations for each time point. (E) Zika virus-neutralizing antibody titers (EC
   <sub>50</sub> values) post-ZIKV infection in ZIKV RMs (blue squares; 
   <italic>n</italic> = 5) and SIV/ZIKV RMs (red circles; 
   <italic>n</italic> = 7). AUCs were calculated from day 0 to day 56. The dashed line represents the limit of detection (LOD).
  </p>
 </caption>
 <graphic xlink:href="mBio.02790-19-f0002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
